Simple and sensitive spectrofluorimetric method for the determination of oseltamivir phosphate in capsules through derivatization with fluorescamine

Journal of Fluorescence

Volumn 19, Issue 4, 2009, Pages 673-679

  Aydoğmuş, Zeynep ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Capsules; Fluorescamine; Oseltamivir phosphate; Spectrofluorimetry

Indexed keywords

FLUORESCENCE;

CAPSULES; EXPERIMENTAL PARAMETERS; FLUORESCAMINES; FLUORESCENCE INTENSITIES; OSELTAMIVIR PHOSPHATES; SPECTRO-PHOTOMETRIC METHOD; SPECTROFLUORIMETRIC METHODS; SPECTROFLUORIMETRY;

SPECTROPHOTOMETRY;

FLUORESCAMINE; OSELTAMIVIR;

ARTICLE; CHEMISTRY; CONFORMATION; INSTRUMENTATION; METHODOLOGY; MICROCAPSULE; PH; SPECTROFLUOROMETRY; TEMPERATURE; TIME; ULTRAVIOLET SPECTROPHOTOMETRY;

CAPSULES; FLUORESCAMINE; HYDROGEN-ION CONCENTRATION; MOLECULAR CONFORMATION; OSELTAMIVIR; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; TEMPERATURE; TIME FACTORS;

EID: 70349252272     PISSN: 10530509     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10895-009-0461-3     Document Type: Article

References (17)

1. K McClellan CM Perry 2001 Oseltamivir: a review of its use in influenza Drugs 61 263 283 11270942 10.2165/00003495-200161020-00011 1:STN:280: DC%2BD3M7nsFSkuw%3D%3D (Pubitemid 32210201)
2. H Wiltshire B Wiltshire A Citron T Clarke C Serpe D Gray W Herron 2000 Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine J Chromatogr B Biomed Sci Appl 745 373 388 11043756 10.1016/S0378-4347(00)00300-5 1:CAS:528:DC%2BD3cXlvFWjsLk%3D (Pubitemid 30665562)
3. WB Dreitlein J Maratos J Brocavich 2001 Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza Clin Ther 23 327 355 11318072 10.1016/S0149-2918(01)80042-4 1:CAS:528:DC%2BD3MXjvVartr4%3D
4. KG Nicholson FY Aoki ADME Osterhaus S Trottier O Carewicz CH Mercier, et al. 2000 Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 355 1845 1850 1:CAS:528:DC%2BD3cXkt1Crsb0%3D
5. EJ Eisenberg KC Cundy 1998 High-performance liquid chromatographic determination of GS4071, a potent inhibitor of influenza neuraminidase, in plasma by precolumn fluorescence derivatization with naphthalenedialdehyde J Chromatogr B Biomed Sci Appl 716 267 273 9824240 10.1016/S0378-4347(98)00268-0 1:CAS:528:DyaK1cXmtl2mu7c%3D (Pubitemid 28464571)
6. G Bahrami B Mohammadi A Kiani 2008 Determination of oseltamivir carboxylic acid in human serum by solid phase extraction and high performance liquid chromatography with UV detection J Chromatogr B Analyt Technol Biomed Life Sci 864 38 42 18313995 10.1016/j.jchromb.2008.01.048 1:CAS:528: DC%2BD1cXjtlCisL0%3D
7. C Fuke Y Ihama T Miyazaki 2008 Analysis of oseltamivir active metabolite, oseltamivir carboxylate, in biological materials by HPLC-UV in a case of death following ingestion of Tamiflu Leg Med 10 83 87 10.1016/j.legalmed.2007.07.003 1:CAS:528:DC%2BD1cXlsFeguw%3D%3D
8. W Li PA Escarpe EJ Eisenberg KC Cundy C Sweet KJ Jakeman, et al. 1998 Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071 Antimicrob Agents Chemother 42 647 653 9517946 1:CAS:528:DyaK1cXhvV2ktb8%3D (Pubitemid 28114822)
9. N Lindegårdh W Hanpithakpong Y Wattanagoon P Singhasivanon NJ White NP Day 2007 Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine J Chromatogr B Analyt Technol Biomed Life Sci 859 74 84 17913596 10.1016/j.jchromb.2007.09.018 (Pubitemid 47626090)
10. N Lindegårdh TT Hien J Farrar P Singhasivanon NJ White NP Day 2006 A simple and rapid liquid chromatographic assay for evaluation of potentially counterfeit Tamiflu J Pharm Biomed Anal 42 430 433 16750606 10.1016/j.jpba.2006. 04.028 (Pubitemid 44375104)
11. J Joseph-Charles C Geneste E Laborde-Kummer R Gheyouche H Boudis JP Dubost 2007 Development and validation of a rapid HPLC method for the determination of oseltamivir phosphate in Tamiflu and generic versions J Pharm Biomed Anal 44 1008 1013 17512688 10.1016/j.jpba.2007.04.002 1:CAS:528:DC%2BD2sXot1yhs7k%3D (Pubitemid 47095194)
12. MD Green H Nettey RA Wirtz 2008 Determination of oseltamivir quality by colorimetric and liquid chromatographic methods Emerg Infect Dis 14 552 556 18394271 10.3201/eid1404.061199 1:CAS:528:DC%2BD1cXltFamt70%3D
13. British Pharmacopoeia (1998) Her Majesty's Stationery Office, London, pp 799-800
14. S Udenfriend S Stein P Böhlen W Dairman W Leimgruber M Weigele 1972 Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range Science 178 871 872 5085985 10.1126/science.178.4063.871 1:CAS:528:DyaE3sXis1ShsA%3D%3D
15. T Bantan-Polak M Kassai KB Grant 2001 A comparison of fluorescamine and naphthalene-2,3-dicarboxaldehyde fluorogenic reagents for microplate-based detection of amino acids Anal Biochem 297 128 136 11673879 10.1006/abio.2001. 5338 1:CAS:528:DC%2BD3MXnslWgs70%3D (Pubitemid 32989342)
16. Validation of Analytical Procedures (1996) Methodology ICH harmonised tripartite guideline having reached step 4 of the ICH process at the ICH Steering Committee Meeting on, November 6
17. B Narasimhan K Abida K Srinivas 2008 Stability indicating RP-HPLC method development and validation for oseltamivir API Chem Pharm Bull (Tokyo) 56 413 417 10.1248/cpb.56.413 1:CAS:528:DC%2BD1cXmtlalsb4%3D